In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.